Abstract
Experiments were performed on 30 rabbits. DIC-syndrome was modeled with the drug "Efa-2", made on the basis of the poison of the multi-scaled snake Efa. The obtained experimental model corresponds to the subacute form of the course of DIC-syndrome, which lasts an average of 19 days and in which four stages of the development of the latter can be clearly traced. At the same time, changes developed in the internal organs of the experimental animals, which make it possible to state a violation of microcirculation, which is typical for DIC syndrome.
Publisher
European Scientific Platform (Publications)
Reference8 articles.
1. Levi M. (2003) Disseminated Intravascular Coagulation. Transfusion Alternatives in Transfusion Medicine, 4(6), 212–217. https://doi.org/10.1111/j.1778-428X.2003.tb00084.x
2. Yoshikawa, T., Furukawa, Y., Murakami, M., Takemura, S., & Kondo, M. (1981). Experimental model of disseminated intravascular coagulation induced by sustained infusion of endotoxin. Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 179(3), 223–228. https://doi.org/10.1007/BF01851619
3. Berthelesen L.O., Kristensen A.T., Tranholm M. (2011). Animal models of DIC and their relevance to human DIC: A systematic review. Thrombossis research, 128(2), 103-116. https://doi.org/10.1016/j.thromres.2010.12.002
4. Jeon, Y. J., Kim, J. W., Park, S., & Shin, D. W. (2019). Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study. Acute and critical care, 34(4), 269–275. https://doi.org/10.4266/acc.2019.00591
5. European convention for the protection of vertebrate animals used for experimental and other scientific purpose (1986). Council of Europe 18.03.1986. Strasbourg, 52. Retrieved from https://rm.coe.int/168007a67b